Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy

被引：3
|
作者：
Park, JH
Park, JH
Yang, CW
Kim, YS
Kim, SY
Moon, IS
Koh, YB
Bang, BK
机构：
[1] Catholic Univ Korea, Kangnam St Marys Hosp, Dept Internal Med, Seocho Ku, Seoul 137040, South Korea
[2] Catholic Univ Korea, Kangnam St Marys Hosp, Dept Surg, Seocho Ku, Seoul 137040, South Korea
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(00)01393-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：1747 / 1747
页数：1
相关论文
共 50 条
  • [41] LONG TERM GRAFT FUNCTION IN PEDIATRIC RENAL TRANSPLANT PATIENTS WITH CHRONIC ALLOGRAFT NEPHROPATHY RECEIVING MYCOPHENOLATE MOFETIL.
    Prince, Nicholas J.
    McCulloch, Mignon I.
    Kerecuk, Larissa
    Walsh, Grainne
    Taylor, Judy
    PEDIATRIC TRANSPLANTATION, 2011, 15 : 56 - 56
  • [42] Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection
    Allison, AC
    Eugui, EM
    TRANSPLANTATION, 2005, 80 (02) : S181 - S190
  • [43] Comparison of cyclosporine versus mycophenolate mofetil on expression of fractalkine and CX3CR1 in chronic allograft nephropathy
    Cao, G.
    Lu, Y.
    Gao, R.
    Xin, Y.
    Teng, D.
    Wang, J.
    Wang, L.
    Li, Y.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2234 - 2236
  • [44] Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy
    Yang, CW
    Ahn, HJ
    Kim, WY
    Li, C
    Jung, JY
    Yoon, SA
    Kim, YS
    Cha, JH
    Kim, J
    Bang, BK
    TRANSPLANTATION, 2003, 75 (03) : 309 - 315
  • [45] Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy
    David-Neto, E
    Araujo, LMP
    Lemos, FC
    David, DSR
    Mazzucchi, E
    Nahas, WC
    Arap, S
    Ianhez, LE
    PEDIATRIC TRANSPLANTATION, 2001, 5 (04) : 302 - 309
  • [46] Mycophenolate mofetil reduces graft loss due to chronic allograft nephropaty
    Falkiewicz, K
    Kuriata, M
    Boratynska, M
    Klinger, M
    Szepietowski, T
    Patrzalek, D
    Szyber, P
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (02) : 567 - 568
  • [47] Mycophenolate mofetil in IgA nephropathy - Reply
    Maes, BD
    Vanrenterghem, YFC
    KIDNEY INTERNATIONAL, 2004, 66 (04) : 1713 - 1714
  • [48] Improvement of renal transplant function by reduction of calcineurin inhibitor and introduction of mycophenolate mofetil acid in patients with chronic allograft nephropathy.
    Merkel, Saskia
    Mengel, Michael
    Haller, Hermann
    Schwarz, Anke
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 533 - 533
  • [49] Low-dose mycophenolate mofetil is an effective and safe treatment to permit phased reduction in calcineurin inhibitors in chronic allograft nephropathy
    Aftali, B
    Shah, S
    Chowdhury, P
    O'Sullivan, H
    Taylor, J
    Goldsmith, D
    TRANSPLANTATION, 2005, 79 (03) : 304 - 309
  • [50] Potential benefit of mycophenolate mofetil (MMF) on chronic allograft nephropathy (CAN) and cardiovascular disease (CVD) due to attenuation of macrophage response
    Grebe, Scott O.
    Trebst, Ruediger
    Mueller, Thomas F.
    Kuhlmann, Uwe
    TRANSPLANT INTERNATIONAL, 2007, 20 : 240 - 240
12345